Occurrence of virulence determinants in vibrio cholerae, vibrio mimicus, vibrio alginolyticus, and vibrio parahaemolyticus isolates from important water resources of Eastern Cape, South Africa.


Journal

BMC microbiology
ISSN: 1471-2180
Titre abrégé: BMC Microbiol
Pays: England
ID NLM: 100966981

Informations de publication

Date de publication:
28 10 2023
Historique:
received: 28 03 2023
accepted: 12 10 2023
medline: 30 10 2023
pubmed: 28 10 2023
entrez: 27 10 2023
Statut: epublish

Résumé

Virulence determinants are crucial to the risk assessment of pathogens in an environment. This study investigated the presence of eleven key virulence-associated genes in Vibrio cholerae (n = 111) and Vibrio mimicus (n = 22) and eight virulence determinants in Vibrio alginolyticus (n = 65) and Vibrio parahaemolyticus (n = 17) isolated from six important water resources in Eastern Cape, South Africa, using PCR techniques. The multiple virulence gene indexes (MVGI) for sampling sites and isolates as well as hotspots for potential vibriosis outbreaks among sampling sites were determined statistically based on the comparison of MVGI. The PCR assay showed that all the V. cholerae isolates belong to non-O1/non-O139 serogroups. Of the isolates, Vibrio Cholera (84%), V. mimicus (73%), V. alginolyticus (91%) and V. parahaemolyticus (100%) isolates harboured at least one of the virulence-associated genes investigated. The virulence gene combinations detected in isolates varied at sampling site and across sites. Typical virulence-associated determinants of V. cholerae were detected in V. mimicus while that of V. parahaemolyticus were detected in V. alginolyticus. The isolates with the highest MVGI were recovered from three estuaries (Sunday river, Swartkopps river, buffalo river) and a freshwater resource (Lashinton river). The cumulative MVGI for V. cholerae, V. mimicus, V. alginolyticus and V. parahaemolyticus isolates were 0.34, 0.20, 0.45, and 0.40 respectively. The targeted Vibrio spp. in increasing order of the public health risk posed in our study areas based on the MVGI is V. alginolyticus > V. parahaemolyticus > V. cholerae > V. mimicus. Five (sites SR, PA5, PA6, EL4 and EL6) out of the seventeen sampling sites were detected as the hotspots for potential cholera-like infection and vibriosis outbreaks. Our findings suggest that humans having contact with water resources in our study areas are exposed to potential public health risks owing to the detection of virulent determinants in human pathogenic Vibrio spp. recovered from the water resources. The study affirms the relevancy of environmental Vibrio species to the epidemiology of vibriosis, cholera and cholera-like infections. Hence we suggest a monitoring program for human pathogenic Vibrio spp. in the environment most especially surface water that humans have contact with regularly.

Sections du résumé

BACKGROUND
Virulence determinants are crucial to the risk assessment of pathogens in an environment. This study investigated the presence of eleven key virulence-associated genes in Vibrio cholerae (n = 111) and Vibrio mimicus (n = 22) and eight virulence determinants in Vibrio alginolyticus (n = 65) and Vibrio parahaemolyticus (n = 17) isolated from six important water resources in Eastern Cape, South Africa, using PCR techniques. The multiple virulence gene indexes (MVGI) for sampling sites and isolates as well as hotspots for potential vibriosis outbreaks among sampling sites were determined statistically based on the comparison of MVGI.
RESULT
The PCR assay showed that all the V. cholerae isolates belong to non-O1/non-O139 serogroups. Of the isolates, Vibrio Cholera (84%), V. mimicus (73%), V. alginolyticus (91%) and V. parahaemolyticus (100%) isolates harboured at least one of the virulence-associated genes investigated. The virulence gene combinations detected in isolates varied at sampling site and across sites. Typical virulence-associated determinants of V. cholerae were detected in V. mimicus while that of V. parahaemolyticus were detected in V. alginolyticus. The isolates with the highest MVGI were recovered from three estuaries (Sunday river, Swartkopps river, buffalo river) and a freshwater resource (Lashinton river). The cumulative MVGI for V. cholerae, V. mimicus, V. alginolyticus and V. parahaemolyticus isolates were 0.34, 0.20, 0.45, and 0.40 respectively. The targeted Vibrio spp. in increasing order of the public health risk posed in our study areas based on the MVGI is V. alginolyticus > V. parahaemolyticus > V. cholerae > V. mimicus. Five (sites SR, PA5, PA6, EL4 and EL6) out of the seventeen sampling sites were detected as the hotspots for potential cholera-like infection and vibriosis outbreaks.
CONCLUSIONS
Our findings suggest that humans having contact with water resources in our study areas are exposed to potential public health risks owing to the detection of virulent determinants in human pathogenic Vibrio spp. recovered from the water resources. The study affirms the relevancy of environmental Vibrio species to the epidemiology of vibriosis, cholera and cholera-like infections. Hence we suggest a monitoring program for human pathogenic Vibrio spp. in the environment most especially surface water that humans have contact with regularly.

Identifiants

pubmed: 37891478
doi: 10.1186/s12866-023-03060-z
pii: 10.1186/s12866-023-03060-z
pmc: PMC10612165
doi:

Substances chimiques

Virulence Factors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

316

Informations de copyright

© 2023. The Author(s).

Références

Lett Appl Microbiol. 2005;41(2):202-7
pubmed: 16033522
J Clin Microbiol. 2001 Nov;39(11):4086-92
pubmed: 11682534
Sci Rep. 2020 Aug 31;10(1):14329
pubmed: 32868874
J Infect. 2013 May;66(5):432-8
pubmed: 23201968
Epidemiol Infect. 2016 Nov;144(15):3335-3341
pubmed: 27510301
J Clin Microbiol. 2015 Jan;53(1):9-14
pubmed: 25339398
Clin Infect Dis. 2008 Oct 15;47(8):1035-40
pubmed: 18781876
Microbes Infect. 2011 Nov;13(12-13):992-1001
pubmed: 21782964
Clin Microbiol Rev. 2013 Apr;26(2):185-230
pubmed: 23554414
Infect Immun. 2002 Jan;70(1):121-6
pubmed: 11748172
Infect Immun. 2015 May 4;83(7):2862-2869
pubmed: 25939511
mBio. 2011 Jun 14;2(3):e00106-11
pubmed: 21673189
Front Microbiol. 2015 Mar 05;6:144
pubmed: 25798132
PLoS One. 2016 Jan 05;11(1):e0144885
pubmed: 26730584
Int J Infect Dis. 2015 Jun;35:117-9
pubmed: 25975654
FEMS Microbiol Ecol. 2012 Dec;82(3):563-73
pubmed: 22676367
Front Microbiol. 2021 Aug 20;12:726273
pubmed: 34489915
J Med Microbiol. 2010 Oct;59(Pt 10):1260-1262
pubmed: 20616193
J Med Microbiol. 2013 Jun;62(Pt 6):917-921
pubmed: 23449872
J Clin Microbiol. 1998 Mar;36(3):756-63
pubmed: 9508308
Eur J Clin Microbiol Infect Dis. 2009 Apr;28(4):421-4
pubmed: 18925423
BMC Microbiol. 2010 Nov 30;10:306
pubmed: 21118541
Proc Natl Acad Sci U S A. 2010 Dec 7;107(49):21134-9
pubmed: 21078967
Appl Environ Microbiol. 2000 Sep;66(9):4022-8
pubmed: 10966424
Int J Environ Res Public Health. 2021 Jun 24;18(13):
pubmed: 34202418
Infect Immun. 2003 Feb;71(2):1020-5
pubmed: 12540588
J Bacteriol. 2003 Dec;185(23):6893-901
pubmed: 14617653
Rev Inst Med Trop Sao Paulo. 2006 Mar-Apr;48(2):65-70
pubmed: 16699625
Future Microbiol. 2007 Jun;2(3):335-44
pubmed: 17661707
An Acad Bras Cienc. 2017 Apr-Jun;89(2):1175-1188
pubmed: 28489191
Front Public Health. 2018 Aug 31;6:237
pubmed: 30234084
Appl Environ Microbiol. 2015 Mar;81(6):1909-18
pubmed: 25556194
Infect Drug Resist. 2020 Apr 28;13:1221-1236
pubmed: 32425560
PLoS One. 2014 Apr 03;9(4):e86264
pubmed: 24699521
Int J Infect Dis. 2018 Sep;74:117-122
pubmed: 29969728
J Clin Microbiol. 2002 Nov;40(11):4321-4
pubmed: 12409420
J Infect Public Health. 2018 Sep - Oct;11(5):601-604
pubmed: 29366858
J Appl Microbiol. 2005;98(5):1011-9
pubmed: 15836469
Appl Environ Microbiol. 2013 Apr;79(7):2358-70
pubmed: 23377932
Mol Microbiol. 1997 Sep;25(6):1003-9
pubmed: 9350858
Front Microbiol. 2017 Apr 21;8:728
pubmed: 28484445
Science. 1996 Jun 28;272(5270):1910-4
pubmed: 8658163
Case Rep Infect Dis. 2015;2015:187212
pubmed: 26605095
Appl Environ Microbiol. 2013 Apr;79(7):2247-52
pubmed: 23354697
Appl Environ Microbiol. 1994 Feb;60(2):756-9
pubmed: 8135527
J Clin Microbiol. 2004 Oct;42(10):4657-71
pubmed: 15472325
Open Microbiol J. 2018 Feb 28;12:18-27
pubmed: 29541268
J Appl Microbiol. 2000 Mar;88(3):475-81
pubmed: 10747228
Rev Argent Microbiol. 2004 Oct-Dec;36(4):158-63
pubmed: 15786867
Infect Immun. 2002 May;70(5):2441-53
pubmed: 11953381
BMC Vet Res. 2019 May 28;15(1):176
pubmed: 31138199
Eur J Clin Microbiol Infect Dis. 2014 May;33(5):767-78
pubmed: 24213848
Nat Rev Dis Primers. 2018 Jul 12;4(1):8
pubmed: 30002421
Proc Natl Acad Sci U S A. 1999 Feb 2;96(3):1071-6
pubmed: 9927695
Front Microbiol. 2021 Jun 02;12:617703
pubmed: 34149632
FEMS Microbiol Rev. 2002 Jun;26(2):125-39
pubmed: 12069878
Proc Natl Acad Sci U S A. 2005 Mar 1;102(9):3465-70
pubmed: 15728357
Int Microbiol. 2016 Dec;19(4):191-198
pubmed: 28504816
Microbiol Immunol. 2004;48(7):547-51
pubmed: 15272201
Emerg Infect Dis. 2013 Mar;19(3):464-7
pubmed: 23622872
Biocontrol Sci. 2008 Mar;13(1):1-8
pubmed: 18432110
Virulence. 2020 Dec;11(1):23-31
pubmed: 31826705
Infect Immun. 2002 Aug;70(8):4735-42
pubmed: 12117994
mBio. 2017 Jul 25;8(4):
pubmed: 28743812
Infect Immun. 2000 Jun;68(6):3180-5
pubmed: 10816461
J Med Microbiol. 2009 Feb;58(Pt 2):239-247
pubmed: 19141743
PLoS One. 2010 Oct 13;5(10):e13365
pubmed: 20967223
J Bacteriol. 1999 Nov;181(21):6779-87
pubmed: 10542181
Microb Pathog. 1997 Apr;22(4):199-208
pubmed: 9140915
Trop Med Health. 2018 Sep 05;46:31
pubmed: 30202236
Front Microbiol. 2016 Feb 11;7:144
pubmed: 26904017
Annu Rev Microbiol. 2018 Sep 08;72:89-110
pubmed: 29897833
Int J Infect Dis. 2014 Aug;25:116-8
pubmed: 24905769
Microb Drug Resist. 2020 Apr;26(4):391-401
pubmed: 31596685
PLoS One. 2013 Sep 23;8(9):e76200
pubmed: 24086707
J Basic Microbiol. 2009 Dec;49(6):538-44
pubmed: 19810041
Appl Environ Microbiol. 2013 Sep;79(18):5782-5
pubmed: 23872570
Vet Pathol. 2014 Mar;51(2):328-40
pubmed: 24318976
Curr Opin Immunol. 2005 Aug;17(4):388-98
pubmed: 15963708
PLoS Negl Trop Dis. 2015 Jun 04;9(6):e0003832
pubmed: 26043000
Southeast Asian J Trop Med Public Health. 2014 Nov;45(6):1365-75
pubmed: 26466422
Epidemiol Infect. 2000 Aug;125(1):27-34
pubmed: 11057956

Auteurs

Oluwatayo E Abioye (OE)

Department of Microbiology, Obafemi Awolowo University, Ife, Nigeria. abioyethayor@gmail.com.

Charles A Osunla (CA)

Department of Microbiology, Adekunle Ajasin University, Akungba Akoko, Nigeria.

Nolonwabo Nontongana (N)

SAMRC Microbial Water Quality Monitoring Centre, University of Fort Hare, Alice, South Africa.

Anthony I Okoh (AI)

SAMRC Microbial Water Quality Monitoring Centre, University of Fort Hare, Alice, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH